BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6290597)

  • 1. Inhibition of vesicular stomatitis virus glycoprotein expression by chloroquine.
    Dille BJ; Johnson TC
    J Gen Virol; 1982 Sep; 62 (Pt 1)():91-103. PubMed ID: 6290597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step.
    Miller DK; Lenard J
    J Cell Biol; 1980 Feb; 84(2):430-7. PubMed ID: 6247355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytopathic effects in mouse neuroblastoma cells during a non-permissive infection with a mutant of vesicular stomatitis virus.
    Dille BJ; Hughes JV; Johnson TC; Rabinowitz SG; Dal Canto MC
    J Gen Virol; 1981 Aug; 55(Pt 2):343-54. PubMed ID: 6270268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of viral membranes: maturation of the vesicular stomatitis virus glycoprotein in the presence of tunicamycin.
    Morrison TG; McQuain CO; Simpson D
    J Virol; 1978 Oct; 28(1):368-74. PubMed ID: 212608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma cell fusion by a temperature-sensitive mutant of vesicular stomatitis virus.
    Hughes JV; Dille BJ; Thimmig RL; Johnson TC; Rabinowitz SG; Dal Canto MC
    J Virol; 1979 Jun; 30(3):883-90. PubMed ID: 225547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and infectivity of vesicular stomatitis virus containing nonglycosylated G protein.
    Gibson R; Leavitt R; Kornfeld S; Schlesinger S
    Cell; 1978 Apr; 13(4):671-9. PubMed ID: 207437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of concanavalin A on vesicular stomatitis virus maturation.
    Cartwright B
    J Gen Virol; 1977 Feb; 34(2):249-56. PubMed ID: 190344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the glycoprotein of vesicular stomatitis virus and its binding to cell surfaces.
    Thimmig RL; Hughes JV; Kinders RJ; Milenkovic AG; Johnson TC
    J Gen Virol; 1980 Oct; 50(2):279-91. PubMed ID: 6257823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH.
    Florkiewicz RZ; Rose JK
    Science; 1984 Aug; 225(4663):721-3. PubMed ID: 6087454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutants of vesicular stomatitis virus blocked at different stages in maturation of the viral glycoprotein.
    Zilberstein A; Snider MD; Porter M; Lodish HF
    Cell; 1980 Sep; 21(2):417-27. PubMed ID: 6250721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
    Kahn JS; Schnell MJ; Buonocore L; Rose JK
    Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation does not determine segregation of viral envelope proteins in the plasma membrane of epithelial cells.
    Green RF; Meiss HK; Rodriguez-Boulan E
    J Cell Biol; 1981 May; 89(2):230-9. PubMed ID: 6265461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein.
    Santoro MG; Jaffe BM; Esteban M
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2797-801. PubMed ID: 6198441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of monensin on the synthesis, maturation and secretion of vesicular stomatitis virus proteins in a monensin-resistant Chinese hamster ovary cell line.
    Ono M; Mannen K; Shimada T; Kuwano M; Mifune K
    Cell Struct Funct; 1985 Sep; 10(3):279-94. PubMed ID: 2994891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin.
    Barquero AA; Alché LE; Coto CE
    J Gen Virol; 2004 Feb; 85(Pt 2):483-493. PubMed ID: 14769906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.